The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Stoll Roger G Phd since year 2005.
The trader's CIK number is 1191281.
At the time of this reporting, Stoll Roger G Phd is the Director of Delcath Systems Inc .
(stock ticker symbol DCTH).
See this page for all insider trading activities at Delcath Systems Inc .
Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|---|
2015-07-27 | DCTH | Delcath Systems Inc | Buy | 20,000 | .54 | 10,740 |
2009-11-18 | DCTH | Delcath Systems Inc | Buy | 25,000 | 3.60 | 90,000 |
2009-08-24 | DCTH | Delcath Systems Inc | Buy | 10,000 | 3.06 | 30,590 |
2009-03-09 | CHTP | Chelsea Therapeutics International, Ltd. | Buy | 22,000 | 1.50 | 33,000 |
2008-09-25 | CHTP | Chelsea Therapeutics International, Ltd. | Buy | 10,000 | 3.24 | 32,450 |
2008-09-08 | CHTP | Chelsea Therapeutics International, Ltd. | Buy | 5,000 | 4.86 | 24,300 |
2008-09-05 | CHTP | Chelsea Therapeutics International, Ltd. | Buy | 5,000 | 4.63 | 23,160 |
2008-06-02 | CHTP | Chelsea Therapeutics International, Ltd. | Buy | 5,000 | 5.45 | 27,254 |
2008-05-30 | CHTP | Chelsea Therapeutics International, Ltd. | Buy | 5,000 | 5.39 | 26,970 |
2008-04-22 | COR | Cortex Pharmaceuticals Inc/de/ | Buy | 20,000 | .75 | 15,000 |
2008-01-25 | COR | Cortex Pharmaceuticals Inc/de/ | Buy | 10,000 | .58 | 5,800 |
2008-01-24 | COR | Cortex Pharmaceuticals Inc/de/ | Buy | 10,000 | .57 | 5,699 |
2007-12-12 | COR | Cortex Pharmaceuticals Inc/de/ | Buy | 10,000 | .65 | 6,500 |
2007-11-21 | COR | Cortex Pharmaceuticals Inc/de/ | Buy | 10,000 | .51 | 5,100 |
2007-11-16 | COR | Cortex Pharmaceuticals Inc/de/ | Buy | 10,000 | .50 | 5,000 |
2005-03-14 | COR | Cortex Pharmaceuticals Inc/de/ | Buy | 5,000 | 2.48 | 12,375 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Stoll Roger G Phd (Director of Delcath Systems Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.